79 related articles for article (PubMed ID: 16077988)
1. Release of bFGF following apoptosis and necrosis in NSCLC cells: effects on chemosensitivity to cisplatin.
Kuhn H; Weser L; Gessner C; Hammerschmidt S; Wirtz H
Oncol Rep; 2005 Sep; 14(3):759-62. PubMed ID: 16077988
[TBL] [Abstract][Full Text] [Related]
2. Influence of basic fibroblast growth factor on the proliferation of non-small cell lung cancer cell lines.
Kuhn H; Köpff C; Konrad J; Riedel A; Gessner C; Wirtz H
Lung Cancer; 2004 May; 44(2):167-74. PubMed ID: 15084381
[TBL] [Abstract][Full Text] [Related]
3. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
5. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
6. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R
Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770
[TBL] [Abstract][Full Text] [Related]
7. Polysaccharide of Cordyceps sinensis enhances cisplatin cytotoxicity in non-small cell lung cancer H157 cell line.
Ji NF; Yao LS; Li Y; He W; Yi KS; Huang M
Integr Cancer Ther; 2011 Dec; 10(4):359-67. PubMed ID: 21382957
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of VEGF following bFGF inhibition in non-small cell lung cancer cell lines.
Kuhn H; Konrad J; Holtz S; Salameh A; Gessner C; Hammerschmidt S; Wirtz H
Lung Cancer; 2006 Nov; 54(2):149-53. PubMed ID: 16934908
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cells.
Zhang LJ; Hao YZ; Hu CS; Ye Y; Xie QP; Thorne RF; Hersey P; Zhang XD
Anticancer Drugs; 2008 Feb; 19(2):159-66. PubMed ID: 18176112
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells.
Woods DC; Alvarez C; Johnson AL
Gynecol Oncol; 2008 Mar; 108(3):632-40. PubMed ID: 18191995
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor and basic fibroblast growth factor are released by squamous cell carcinoma cells after irradiation and increase resistance to subsequent irradiation.
Brieger J; Schroeder P; Gosepath J; Mann WJ
Int J Mol Med; 2005 Jul; 16(1):159-64. PubMed ID: 15942693
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic effects of camptothecin and cisplatin combined with tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) in a model of primary culture of non-small cell lung cancer.
Frese S; Schüller A; Frese-Schaper M; Gugger M; Schmid RA
Anticancer Res; 2009 Aug; 29(8):2905-11. PubMed ID: 19661294
[TBL] [Abstract][Full Text] [Related]
13. Stimulatory heterotrimeric GTP-binding protein augments cisplatin-induced apoptosis by upregulating Bak expression in human lung cancer cells.
Choi YJ; Oh JM; Kim SY; Seo M; Juhnn YS
Cancer Sci; 2009 Jun; 100(6):1069-74. PubMed ID: 19320642
[TBL] [Abstract][Full Text] [Related]
14. [Role of Smac in cisplatin-induced apoptosis of non-small cell lung cancer cells].
Cheng XD; Cai SX; Zhao HJ; Li WJ; Tong WC
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):389-91. PubMed ID: 18359697
[TBL] [Abstract][Full Text] [Related]
15. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
[TBL] [Abstract][Full Text] [Related]
16. Basic fibroblast growth factor sensitizes NIH 3T3 cells to apoptosis induced by cisplatin.
Coleman AB; Momand J; Kane SE
Mol Pharmacol; 2000 Feb; 57(2):324-33. PubMed ID: 10648642
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines.
Koshimune R; Aoe M; Toyooka S; Hara F; Ouchida M; Tokumo M; Sano Y; Date H; Shimizu N
BMC Cancer; 2007 Jan; 7():8. PubMed ID: 17222343
[TBL] [Abstract][Full Text] [Related]
18. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY
Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429
[TBL] [Abstract][Full Text] [Related]
19. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation.
Checinska A; Hoogeland BS; Rodriguez JA; Giaccone G; Kruyt FA
Exp Cell Res; 2007 Apr; 313(6):1215-24. PubMed ID: 17291493
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner.
Wu XX; Kakehi Y
Clin Cancer Res; 2009 Mar; 15(6):2039-47. PubMed ID: 19276256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
